Lipid pharmacotherapy for treatment of atherosclerosis

Author： Nicholls Stephen J Pisaniello Anthony D Kataoka Yu Puri Rishi

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.8, 2014-06, pp. : 1119-1125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Lipid oxidation products and atherosclerosis

By Berliner J.

General Pharmacology, Vol. 38, Iss. 4, 2002-04 ,pp. : 187-191

Elsevier

Access to resources Recommend Favorite

Role of Lipid-Lowering Pharmacotherapy in Children

By Tonstad S.

Pediatric Drugs, Vol. 2, Iss. 1, 2000-01 ,pp. : 11-22

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for treatment-refractory schizophrenia

By Van Sant Scott P Buckley Peter F

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 411-434

Informa Healthcare

Access to resources Recommend Favorite

Lipid Lowering Agents, Inflammation and Atherosclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 206-216

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)

Current Pharmaceutical Design, Vol. 20, Iss. 40, 2014-12 ,pp. : 6215-6219

Bentham Science Publishers

Access to resources Recommend Favorite